{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T04:04:34Z","timestamp":1784433874704,"version":"3.55.0"},"reference-count":36,"publisher":"Bentham Science Publishers Ltd.","issue":"13","funder":[{"DOI":"10.13039\/501100012245","name":"Science and Technology Plan Projects of Guangdong Province","doi-asserted-by":"publisher","award":["2016A050502064"],"award-info":[{"award-number":["2016A050502064"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["ACAMC"],"published-print":{"date-parts":[[2020,9,14]]},"abstract":"<jats:sec>\n<jats:title>Aims:<\/jats:title>\n<jats:p>The purpose of our study was to explore the combination effect of epirubicin and Bacillus\nCalmette Guerin (BCG) and its mechanism.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Bladder cancer is a threat to human health worldwide. Commonly used chemotherapy drugs and\nbiotherapy have significant therapeutic effects on bladder cancer, but the mechanism and combined effects are\nstill unclear.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>To evaluate the anti-cancer effect of epirubicin combined with BCG on human bladder cancer cells,\nour studies were carried out.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The viability of human bladder cancer cells with epirubicin and\/or BCG treatments was\nexamined by Cell Counting Kit-8 (CCK-8) assay. Apoptosis and cell cycle phase were\ndetermined by flow cytometry analysis. Pre-apoptosis factors of caspase-3, p53, B-cell\nlymphoma 2 associated X protein (Bax) and anti-apoptosis factor of B-cell lymphoma 2 (Bcl2) were detected by western blot.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The viability of human bladder cancer with epirubicin or BCG treatment was decreased and the viability\nwith epirubicin combined with BCG treatment was decreased more, which were determined by CCK-8\nassay. Both epirubicin and BCG increased the apoptosis rate of human bladder cancer and arrested more cells\ninto G0\/G1 phase, which were tested by flow cytometry. The expression of caspase-3, p53 and Bax was increased\nand the expression of Bcl-2 was decreased with epirubicin treatment on human bladder cells, which\nwere analyzed by western blot. The expression of caspase-3 and p53 was increased with BCG treatment, which\nwas examined by western blot.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Epirubicin induced apoptosis in human bladder cancer cells by up-regulating the expression of proapoptotic\nfactors (caspase-3, p53 and Bax) and down-regulating the expression of anti-apoptotic factor (Bcl-2).\nBCG promoted apoptosis of human bladder cancer cells by up-regulating the expression of caspase-3 and p53.\nBCG plays a potential role at the time of the combination of epirubicin and BCG on bladder cancer cells in early\nstage. Both epirubicin and BCG affected cell cycle distribution via arresting more bladder cancer cells at G0\/G1\nphase, which ultimately led bladder cancer proliferation in vitro and promoted apoptosis.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871520620666200502004002","type":"journal-article","created":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T00:26:47Z","timestamp":1588379207000},"page":"1571-1581","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Apoptosis Mechanism of Epirubicin Combined with BCG on Human Bladder Cancer Cells"],"prefix":"10.2174","volume":"20","author":[{"given":"Yang","family":"Luo","sequence":"first","affiliation":[{"name":"School of Bioscience and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Fu","sequence":"additional","affiliation":[{"name":"School of Bioscience and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Han","sequence":"additional","affiliation":[{"name":"School of Bioscience and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fafu","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Bioscience and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Yuan","sequence":"additional","affiliation":[{"name":"School of Bioscience and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongsheng","family":"Men","sequence":"additional","affiliation":[{"name":"University of Missouri, Columbia, MO, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shanghai Jiao Tong University, Shanghai 200025, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujuan","family":"Tian","sequence":"additional","affiliation":[{"name":"School of Bioscience and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Dong","sequence":"additional","affiliation":[{"name":"School of Bioscience and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7001-7399","authenticated-orcid":true,"given":"Minjie","family":"Meng","sequence":"additional","affiliation":[{"name":"School of Bioscience and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou 510006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68(1)","author":"Siegel, R.L.","year":"2018","unstructured":"Siegel, R.L.; Miller, K.D.; Jemal, A. Cancer statistics. 2018. CA Cancer J. Clin. 2018,68(1),7-30. http:\/\/dx.doi.org\/10.3322\/caac.21442 PMID: 29313949","journal-title":"CA Cancer J.Clin"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/ggi.13165","volume":"18(2)","author":"Matsuda,Y.","year":"2018","unstructured":"Matsuda,Y.; Seki,A.; Nonaka,K.; Kakizaki,M.; Wang,T.; Aida,J.; Ishikawa,N.; Nakano,Y.; Kaneda,D.; Takata,T.; Tak ahashi-Fujigasaki,J.; Murayama,S.; Takubo,K.; Ishiwata,T.; Sawabe,M.; Arai, T. Clinicopathological characteristics of distant metasta-ses of adenocarcinoma, squamous cell carcinoma and urothelial carcinoma: An autopsy study of older Japanese patients. Geriatr. Gerontol. Int. 2018,18(2),211-215. http:\/\/dx.doi.org\/10.1111\/ggi.13165 PMID: 28914998","journal-title":"Geriatr.Gerontol.Int"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"E3393.","DOI":"10.3390\/ijerph16183393","volume":"16(18)","author":"Morales,J.","year":"2019","unstructured":"Morales,J.; Malles,A.; Kimble,M.; Rodriguez-de la Vega,P.; Castro,G.; Nieder, A.M.; Barengo, N.C. Does health insurance modify the association between race and cancer-specific survival in patients with urinary bladder malignancy in the U.S.? Int, J. Envi-ron. Res. Public Health. 2019,16(18),E3393. http:\/\/dx.doi.org\/10.3390\/ijerph16183393 PMID: 31540198","journal-title":"Envi-ron.Res.Public Health"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1002\/(SICI)","volume":"88(7)","author":"Cheng,L.","year":"2000","unstructured":"Cheng,L.; Neumann, R.M.; Nehra,A.; Spotts, B.E.; Weaver, A.L.; Bostwick, D.G. Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma. Cancer. 2000,88(7),1663-1670. http:\/\/dx.doi.org\/10.1002\/(SICI). 1097-0142(20000401) 88:7<1663:: AID-CNCR21>3.0.CO.;-8 PMID: 10738225","journal-title":"Cancer"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/his.13225","volume":"71(2)","author":"Hodgson,A.","year":"2017","unstructured":"Hodgson,A.; Xu,B.; Downes, M.R. p53 immunohistochemistry in high-grade urothelial carcinoma of the bladder is prognostically significant. Histopathology. 2017,71(2),296-304. http:\/\/dx.doi.org\/10.1111\/his.13225 PMID: 28342221","journal-title":"Histopathology"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0140-6736(09) 60491-8","volume":"374(9685)","author":"Kaufman, D.S.","year":"2009","unstructured":"Kaufman, D.S.; Shipley, W.U.; Feldman, A.S. Bladder cancer. Lancet. 2009,374(9685),239-249. http:\/\/dx.doi.org\/10.1016\/S0140-6736(09) 60491-8 PMID: 19520422","journal-title":"Lancet"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.2147\/IJN.S189688","volume":"14","author":"Suo,N.","year":"2019","unstructured":"Suo,N.; Wang,M.; Jin,Y.; Ding,J.; Gao,X.; Sun,X.; Zhang,H.; Cui,M.; Zheng,J.; Li,N.; Jin,X.; Jiang, S. Magnetic multiwalled carbon nanotubes with controlled release of epirubicin: An intrave-sical instillation system for bladder cancer. Int, J. Nanomed. 2019,14,1241-1254. http:\/\/dx.doi.org\/10.2147\/IJN.S189688 PMID: 30863057","journal-title":"Int, J.Nanomed"},{"key":"ref=8","author":"Jiang, H.P.","unstructured":"Jiang, H.P.; Zhu, J.X.; Peng,C.; Gao,J.; Zheng,F.; Xiao, Y.X.; Feng, Y.Q.; Yuan, B.F. Facile one-pot synthesis of a aptamer-based organic-silica hybrid monolithic capillary column by \u201cthiol-ene\u201d click chemistry for detection of enantiomers of chemotherapeutic anthracyclines. Analyst (Lond.),2014,139(19),4940-4946. http:\/\/dx.doi.org\/10.1039\/C4AN00767K PMID: 25072056","journal-title":"Analyst (Lond.)"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"7543","DOI":"10.1158\/1078-0432.CCR-16-3142","volume":"23(24)","author":"Smyth,E.","year":"2017","unstructured":"Smyth,E.; Zhang,S.; Cunningham,D.; Wotherspoon,A.; Soong,R.; Peckitt,C.; Valeri,N.; Fassan,M.; Rugge,M.; Okines,A.; Al-lum,W.; Stenning,S.; Nankive-ll,M.; Langley,R.; Tan, P. Pharma-cogenetic Analysis of the UK MRC (Medical Research Council)  MAGIC Trial: Association of polymorphisms with toxicity and survival in patients treated with perioperative epirubicin, cisplatin, and 5-fluorouracil (ECF)  chemotherapy. Clin. Cancer Res. 2017,23(24),7543-7549. http:\/\/dx.doi.org\/10.1158\/1078-0432.CCR-16-3142 PMID: 28972045","journal-title":"Clin.Cancer Res"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.urolonc.2010.02.007","volume":"30(3)","author":"Librenjak,D.","year":"2012","unstructured":"Librenjak,D.; Situm,M.; Vrdoljak,E.; Milostic,K.; Gotovac, J. Results of long-term follow-up of patients with superficial bladder carcinoma treated with intravesically applied bacillus Calmette-Guerin vaccine according to the schedule of 6 weekly + 6 monthly instillations. Urol. Oncol. 2012,30(3),259-265. http:\/\/dx.doi.org\/10.1016\/j.urolonc.2010.02.007 PMID: 20843705","journal-title":"Urol.Oncol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/S0140-6736(98) 07422-4","volume":"353(9165)","author":"Alexandroff, A.B.","year":"1999","unstructured":"Alexandroff, A.B.; Jackson, A.M.; O\u2019Donnell, M.A.; James, K. BCG immunotherapy of bladder cancer: 20 years on. Lancet. 1999,353(9165),1689-1694. http:\/\/dx.doi.org\/10.1016\/S0140-6736(98) 07422-4 PMID: 10335805","journal-title":"Lancet"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2174\/1874285801812010041","volume":"12","author":"Azadi,D.","year":"2018","unstructured":"Azadi,D.; Motallebirad,T.; Ghaffari,K.; Shojaei, H. Mycobacteri-osis and Tuberculosis: Laboratory diagnosis. Open Microbiol, J. 2018,12,41-58. http:\/\/dx.doi.org\/10.2174\/1874285801812010041 PMID: 29785215","journal-title":"Open Microbiol, J"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2186.","DOI":"10.3390\/ijms 18102186","volume":"18(10)","author":"Miyake,M.","year":"2017","unstructured":"Miyake,M.; Tatsumi,Y.; Gotoh,D.; Ohnishi,S.; Owari,T.; Iida,K.; Ohnishi,K.; Hori,S.; Morizawa,Y.; Itami,Y.; Nakai,Y.; Inoue,T.; Anai,S.; Torimoto,K.; Aoki,K.; Shimada,K.; Konishi,N.; Tanaka,N.; Fujimoto, K. Regulatory T Cells and tumor-associated macrophages in the tumor microenvironment in non-muscle invasive bladder cancer treated with intravesical bacille Calmette-Gu\u00e9rin: A long-term follow-up study of a Japanese co-hort. Int, J. Mol. Sci. 2017,18(10),2186. http:\/\/dx.doi.org\/10.3390\/ijms 18102186 PMID: 29048388","journal-title":"Int, J.Mol.Sci"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1056\/NEJM199110243251703","volume":"325(17)","author":"Lamm, D.L.B.B.","year":"1991","unstructured":"Lamm, D.L.B.B.; Blumenstein, B.A.; Crawford, E.D.; Montie, J.E.; Scardino,P.; Grossman, H.B.; Stanisic, T.H.; Smith, J.A. Jr; Sulli-van,J.; Sarosdy, M.F. A randomized trial of intravesical doxorubi-cin and immunotherapy with bacille Calmette-Gu\u00e9rin for transi-tional-cell carcinoma of the bladder, N. Engl, J. Med. 1991,325(17),1205-1209. http:\/\/dx.doi.org\/10.1056\/NEJM199110243251703 PMID: 1922207","journal-title":"N.Engl, J.Med"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/cas.12075","volume":"104(1)","author":"Kawai,K.","year":"2013","unstructured":"Kawai,K.; Miyazaki,J.; Joraku,A.; Nishiyama,H.; Akaza, H. Bacillus Calmette-Guerin (BCG)  imm unotherapy for bladder can-cer: Current understanding and perspectives on engineered BCG vaccine. Cancer Sci. 2013,104(1),22-27. http:\/\/dx.doi.org\/10.1111\/cas.12075 PMID: 23181987","journal-title":"Cancer Sci"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s00253-012-4416-2","volume":"97(4)","author":"Begnini, K.R.","year":"2013","unstructured":"Begnini, K.R.; Rizzi,C.; Campos, V.F.; Borsuk,S.; Schultze,E.; Yurgel, V.C.; Nedel,F.; Dellagostin, O.A.; Collares,T.; Seixas, F.K. Auxotrophic recombinant Mycobacterium bovis BCG overex-pressing Ag85B enhances cytotoxicity on superficial bladder cancer cells in vitro. Appl. Microbiol. Biotechnol. 2013,97(4),1543-1552. http:\/\/dx.doi.org\/10.1007\/s00253-012-4416-2 PMID: 23053076","journal-title":"Appl.Microbiol.Biotechnol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"68.","DOI":"10.1007\/s11934-016-0625-z","volume":"17(9)","author":"Veeratterapillay,R.","year":"2016","unstructured":"Veeratterapillay,R.; Heer,R.; Johnson, M.I.; Persad,R.; Bach, C. High-risk non-muscle-invasive bladder cancer-therapy options dur-ing intravesical BCG shortage. Curr. Urol. Rep. 2016,17(9),68. http:\/\/dx.doi.org\/10.1007\/s11934-016-0625-z PMID: 27492610","journal-title":"Curr.Urol.Rep"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1158\/0008-5472.CAN-12-1882","volume":"73(3)","author":"Redelman-Sidi,G.","year":"2013","unstructured":"Redelman-Sidi,G.; Iyer,G.; Solit, D.B.; Glickman, M.S. Onco-genic activation of Pak1-dependent pathway of macropinocytosis determines BCG entry into bladder cancer cells. Cancer Res. 2013,73(3),1156-1167. http:\/\/dx.doi.org\/10.1158\/0008-5472.CAN-12-1882 PMID: 23378476","journal-title":"Cancer Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/003655200750024281","volume":"35(2)","author":"Younes,M.","year":"2000","unstructured":"Younes,M.; Lechago,J.; Chakraborty,S.; Ostrowski,M.; Bridges,M.; Meriano,F.; Solcher,D.; Barroso,A.; Whitman,D.; Schwartz,J.; Johnson,C.; Schmulen, A.C.; Verm,R.; Balsaver,A.; Carlson,N.; Ertant, A. Relationship between dysplasia, p53 protein accumu-lation, DNA ploidy, and Glut1 overexpression in Barrett metapla-sia. Scand, J. Gastroenterol. 2000,35(2),131-137. http:\/\/dx.doi.org\/10.1080\/003655200750024281 PMID: 10720109","journal-title":"Scand, J.Gastroenterol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.eururo.2015.05.050","volume":"69(2)","author":"Sylvester, R.J.","year":"2016","unstructured":"Sylvester, R.J.; Oosterlinck,W.; Holmang,S.; Sydes, M.R.; Birtle,A.; Gudjonsson,S.; De Nunzio,C.; Okamura,K.; Kaasinen,E.; Solsona,E.; Ali-El-Dein,B.; Tatar, C.A.; Inman, B.A.; N\u2019Dow,J.; Oddens, J.R.; Babjuk, M. Systematic review and individual patient data meta-analysis of randomized trials comparing a single imme-diate instillation of chemotherapy after transurethral resection with transurethral resection alone in patients with stage pTa-pT1 urothe-lial carcinoma of the bladder: Which patients benefit from the in-stillation? Eur. Urol. 2016,69(2),231-244. http:\/\/dx.doi.org\/10.1016\/j.eururo.2015.05.050 PMID: 26091833","journal-title":"Urol"},{"key":"ref=21","first-page":"1048","volume":"33(6)","author":"Zhan, Y.X.","year":"2017","unstructured":"Zhan, Y.X.; Chen, Q.B.; Lg, X.X.; Qin, X.P.; Chen, J.F.; Huang, B.Y.; Huang,J.; Zhuo, Y.M. Berberine promotes epirubicin-induced G 0\/G1 phase arrest in T24 bladder cancer cells. Chin, J. Pathophysiol. 2017,33(6),1048-1052","journal-title":"Chin, J..Pathophysiol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s10495-018-1450-2","volume":"23(3-4)","author":"Huang, T.C.","year":"2018","unstructured":"Huang, T.C.; Chiu, P.R.; Chang, W.T.; Hsieh, B.S.; Huang, Y.C.; Cheng, H.L.; Huang, L.W.; Hu, Y.C.; Chang, K.L. Epirubicin in-duces apoptosis in osteoblasts through death-receptor and mito-chondrial pathways. Apoptosis. 2018,23(3-4),226-236. http:\/\/dx.doi.org\/10.1007\/s10495-018-1450-2 PMID: 29468482","journal-title":"Apoptosis"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S1097-2765(01) 00214-3","volume":"7(3)","author":"Nakano,K.","year":"2001","unstructured":"Nakano,K.; Vousden, K.H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell. 2001,7(3),683-694. http:\/\/dx.doi.org\/10.1016\/S1097-2765(01) 00214-3 PMID: 11463392","journal-title":"Mol.Cell"},{"key":"ref=24","author":"Yu,J.","unstructured":"Yu,J.; Zhang, L. PUMA, a potent killer with or wit hout p53. On-cogene. 2008,27(Suppl. 1),S71-S83. http:\/\/dx.doi.org\/10.1038\/onc.2009.45 PMID: 19641508","journal-title":"On-cogene"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.fsi.2016.12.026","volume":"61","author":"Reshi,L.","year":"2017","unstructured":"Reshi,L.; Wang, H.V.; Hui, C.F.; Su, Y.C.; Hong, J.R. Anti-apoptotic genes Bcl-2 and Bcl-xL overexpression can block iridovi-rus serine\/threonine kinase-induced Bax\/mitochondria-mediated cell death in GF-1 cells. Fish Shellfish Immunol. 2017,61,120-129. http:\/\/dx.doi.org\/10.1016\/j.fsi.2016.12.026 PMID: 28025159","journal-title":"Fish Shellfish Immunol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s00204-013-1034-4","volume":"87(7)","author":"Sinha,K.","year":"2013","unstructured":"Sinha,K.; Das,J.; Pal, P.B.; Sil, P.C. Oxidative stress: The mito-chondria-dependent and mitochondria-independent pathways of apoptosis. Arch. Toxicol. 2013,87(7),1157-1180. http:\/\/dx.doi.org\/10.1007\/s00204-013-1034-4 PMID: 23543009","journal-title":"Arch.Toxicol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1046\/j.1464-410X.1997.30717.x","volume":"79(1)","author":"Chaudhary, K.S.","year":"1997","unstructured":"Chaudhary, K.S.; Lu, Q.L.; Abel, P.D.; Khandan-Nia,N.; Shoma, A.M.; el Baz,M.; Stamp, G.W.; Lalani, E.N. Expression of bcl-2 and p53 oncoproteins in schistosomiasis-associated trans itional and squamous cell carcinoma of urinary bladder. Br, J. Urol. 1997,79(1),78-84. http:\/\/dx.doi.org\/10.1046\/j.1464-410X.1997.30717.x PMID: 9043502","journal-title":"Br, J.Urol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"10491","DOI":"10.1074\/jbc.M412819200","volume":"280(11)","author":"Weng,C.","year":"2005","unstructured":"Weng,C.; Li,Y.; Xu,D.; Shi,Y.; Tang, H. Specific cleavage of Mcl-1 by caspase-3 in Tumor necrosis factor-Related Apoptosis-Inducing Ligand (TRAIL)-induced apoptosis in Jurkat leukemia T cells, J. Biol. Chem. 2005,280(11),10491-10500. http:\/\/dx.doi.org\/10.1074\/jbc.M412819200 PMID: 15637055","journal-title":"Biol.Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj3260001","volume":"326(Pt 1)","author":"Cohen,G.M","year":"1997","unstructured":"Cohen.; G.M. Caspases: The executioners of apoptosis. Biochem, J. 1997,326(Pt 1),1-16. http:\/\/dx.doi.org\/10.1042\/bj3260001 PMID: 9337844","journal-title":"Biochem, J"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jep.2019.01.007","volume":"234","author":"Xu,Z.","year":"2019","unstructured":"Xu,Z.; Zhang,F.; Zhu,Y.; Liu,F.; Chen,X.; Wei,L.; Zhang,N.; Zhou,Q.; Zhong,H.; Yao,C.; Zhu,X.; Gong,C.; Zhu,S.; Zou, C. Traditional Chinese medicine Ze-Qi-Tang formula inhibit growth of non-small-cell lung cancer cells through the p53 pathway, J. Ethnopharmacol. 2019,234,180-188. http:\/\/dx.doi.org\/10.1016\/j.jep.2019.01.007 PMID: 30660711","journal-title":"Ethnopharmacol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0092-8674(95) 90412-3","volume":"80(2)","author":"Miyashita,T.","year":"1995","unstructured":"Miyashita,T.; Reed, J.C. Tumor suppressor p53 is a direct tran-scriptional activator of the human bax gene. Cell. 1995,80(2),293-299. http:\/\/dx.doi.org\/10.1016\/0092-8674(95) 90412-3 PMID: 7834749","journal-title":"Cell"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1242\/dmm.008888","volume":"5(3)","author":"Ahmad,I.","year":"2012","unstructured":"Ahmad,I.; Sansom, O.J.; Leung, H.Y. Exploring molecular genet-ics of bladder cancer: Lessons learned from mouse models. Dis. Model. Mech. 2012,5(3),323-332. http:\/\/dx.doi.org\/10.1242\/dmm.008888 PMID: 22422829","journal-title":"Dis.Model.Mech"},{"key":"ref=33","first-page":"1874","volume":"7(9)","author":"Gao, S.B.","year":"2017","unstructured":"Gao, S.B.; Li, K.L.; Qiu,H.; Zhu, L.Y.; Pan, C.B.; Zhao,Y.; Wei, S.H.; Shi,S.; Jin, G.H.; Xue, L.X. Enhancing chemotherapy sensi-tivity by targeting PcG via the ATM\/p53 pathway. Am, J. Cancer Res. 2017,7(9),1874-1883. PMID: 28979810","journal-title":"Am, J.Cancer Res"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.echo.2013.10.008","volume":"27(1)","author":"Florescu,M.","year":"2014","unstructured":"Florescu,M.; Magda, L.S.; Enescu, O.A.; Jinga,D.; Vinereanu, D. Early detection of epirubicin-induced cardiotoxicity in patients with breast cancer, J. Am. Soc. Echocardiogr. 2014,27(1),83-92. http:\/\/dx.doi.org\/10.1016\/j.echo.2013.10.008 PMID: 24268372","journal-title":"Am.Soc.Echocardiogr"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","volume":"71(3)","author":"Babjuk,M.","year":"2017","unstructured":"Babjuk,M.; B\u00f6hle,A.; Burger,M.; Capoun,O.; Cohen,D.; Com-p\u00e9rat, E.M.; Hern\u00e1ndez,V.; Kaasinen,E.; Palou,J.; Roupr\u00eat,M.; van Rhijn, B.W.; Shariat, S.F.; Soukup,V.; Sylvester, R.J.; Zige-uner, R. EAU guidelines on non-muscle-invasive urothelial carci-noma of the bladder: Update 2016. Eur. Urol. 2017,71(3),447-461. http:\/\/dx.doi.org\/10.1016\/j.eururo.2016.05.041 PMID: 27324428","journal-title":"Eur.Urol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"bio032045.","DOI":"10.1242\/bio.032045","volume":"7(6)","author":"Kumar,P.","year":"2018","unstructured":"Kumar,P.; John,V.; Gupta,A.; Bhaskar, S. Enhanced survival of BCG-stimulated dendritic cells: Involvement of anti-apoptotic pro-teins and NF-?B. Biol. Open. 2018,7(6),bio032045. http:\/\/dx.doi.org\/10.1242\/bio.032045 PMID: 29848490","journal-title":"Biol.Open"}],"container-title":["Anti-Cancer Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/181560","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T19:32:38Z","timestamp":1602358358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/181560\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,14]]},"references-count":36,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2020,9,14]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871520620666200502004002","relation":{},"ISSN":["1871-5206"],"issn-type":[{"value":"1871-5206","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,14]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-10-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}